M. Frank Erasmus
M. Frank Erasmus publishes mostly in Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology, on topics such as Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research and Protein purification and stability.
- World rank
- #2,265,467 of 7,710,434 ranked researchers
- Rank in United States
- #677,234 of 1,627,098
- Works
- 28
- Citations
- 411
- Citations per work
- 14.7
What does M. Frank Erasmus research?
M. Frank Erasmus's work is mostly in Medicine (42%), Biochemistry, Genetics and Molecular Biology (33%), Immunology and Microbiology (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1345.2%
- Health Sciences1242.4%
- Medicine1242.4%
- Everything else312.4%
- 1Molecular Biology33% of their works
- 2Radiology, Nuclear Medicine and Imaging27% of their works
- 3Immunology12% of their works
- 4Public Health, Environmental and Occupational Health7% of their works
- 5Oncology4% of their works
- 6Infectious Diseases4% of their works
Research topics
- Monoclonal and Polyclonal Antibodies Research
- Glycosylation and Glycoproteins Research
- Protein purification and stability
- T-cell and B-cell Immunology
- Acute Lymphoblastic Leukemia research
- vaccines and immunoinformatics approaches
- Advanced Biosensing Techniques and Applications
- Biosimilars and Bioanalytical Methods
Which keywords describe M. Frank Erasmus's research?
The keywords of their largest research topics: Monoclonal Antibodies, Glycosylation, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Biopharmaceuticals, Immunogenicity and Cancer.
- Peptide-MHC Binding
- Epitope Prediction
- Bioanalytical Methods
- Foxp3
- Acute Lymphoblastic Leukemia
- Protein Aggregation
- Cancer
- Biopharmaceuticals
- Antibody Engineering
- Glycosylation
- Monoclonal Antibodies
- Therapeutic Antibodies
- Fc Receptors
- Immunogenicity
- Glycans
- Recombinant Proteins
- Childhood Cancer
- TGF-ß
- Biosimilars
- High-Throughput Analysis
- Protein Microarrays
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Monoclonal Antibodies303 topics
- Glycosylation272 topics
- Therapeutic Antibodies272 topics
- Antibody Engineering201 topic
- Fc Receptors201 topic
- Biopharmaceuticals102 topics
- Immunogenicity102 topics
- Cancer71 topic
- Glycans71 topic
- Protein Aggregation71 topic
- Recombinant Proteins71 topic
- Acute Lymphoblastic Leukemia51 topic
- Childhood Cancer51 topic
- Foxp351 topic
- TGF-ß51 topic
- Bioanalytical Methods31 topic
- Biosimilars31 topic
- Epitope Prediction31 topic
- High-Throughput Analysis31 topic
- Peptide-MHC Binding31 topic
- Protein Microarrays31 topic
Where does M. Frank Erasmus work?
M. Frank Erasmus's main affiliation in the publication record is Specifica (United States), United States.
How many publications and citations does M. Frank Erasmus have?
OpenAlex counts 28 works and 411 citations for M. Frank Erasmus, an h-index of 11, ranking #2,265,467 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about M. Frank Erasmus. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.